Position in NUVB
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$3,811,512
New position
Shares Held
671,041
first reported quarter
Ownership
0.191%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#42
of 242 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 51%
Shared 0%
None 49%
Position in Biotechnology
Healthcare · as of Jun 30, 2026ESSEX INVESTMENT MANAGEMENT CO LLC holds $67,663,995 across 13 Biotechnology names. NUVB ranks #9 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
43,567 | $13,771,093 | |
| 2 | MIRM |
Mirum Pharmaceuticals, Inc.
|
105,669 | $12,370,669 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
|
133,866 | $7,604,927 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
21,665 | $5,220,615 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
482,154 | $4,734,752 | |
| 6 | INSM |
INSMED Inc
|
42,991 | $4,583,700 | |
| 7 | PGEN |
Precigen, Inc.
|
706,294 | $4,025,875 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
16,244 | $3,976,043 |
All Filings in NUVB
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,811,512 | 671,041 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||